Blood–brain barrier

The barrier is formed chiefly by brain microvascular endothelial cells whose junctions sharply restrict movement between cells. These endothelial cells have unusually low rates of vesicular transport, few fenestrations, and specialized transport proteins; they are supported by pericytes, a basement membrane, and astrocyte endfeet within the neurovascular unit.¹

This arrangement does not make the brain completely isolated. Oxygen and carbon dioxide diffuse readily, while glucose, amino acids, ions, and other essential substances cross through regulated carriers or channels. Efflux transporters, including P-glycoprotein and breast cancer resistance protein, return many lipid-soluble drugs and potentially harmful compounds to the blood.² Barrier properties also vary with vessel size, brain region, age, and physiological state.

Substances cross the barrier through passive diffusion, carrier-mediated transport, receptor-mediated transcytosis, or limited adsorptive transport. Small lipid-soluble molecules can diffuse through endothelial membranes, whereas large proteins such as insulin and transferrin depend on receptor-associated pathways; many hydrophilic nutrients require dedicated carriers.¹

Barrier behavior is regulated dynamically rather than being fixed. Endothelial cells receive signals from neurons, pericytes, astrocytes, microglia, circulating hormones, and blood-borne inflammatory mediators. Tight-junction proteins such as claudins and occludin help seal the paracellular route, while endothelial transporters determine which compounds enter or leave. This regulation couples vascular activity to neural metabolism and contributes to neurovascular coupling, the adjustment of local blood flow to neuronal demand.

Barrier disruption can expose neural tissue to plasma proteins, inflammatory signals, toxins, and fluctuating ions. It occurs in conditions including ischemic stroke, traumatic brain injury, multiple sclerosis, infection, tumors, and some neurodegenerative diseases, although the pattern and consequences differ among disorders.

The same protective selectivity complicates treatment: many antibiotics, biologic medicines, and anticancer drugs reach the brain poorly. Researchers have investigated transient osmotic opening, focused ultrasound, receptor-targeted “shuttle” molecules, nanoparticle delivery, and direct administration into cerebrospinal fluid. Each approach must balance improved drug access against edema, inflammation, neurotoxicity, and loss of barrier protection.³ A leaky barrier is therefore a disease feature, not automatically a useful therapeutic gateway.

The barrier is not continuous across every brain structure. Circumventricular organs, including the area postrema and subfornical organ, contain specialized fenestrated vessels that allow blood-borne signals to be sampled; some are involved in hormone regulation, thirst, vomiting, or immune surveillance.²

The blood–brain barrier is also distinct from the blood–cerebrospinal-fluid barrier, which is associated mainly with the choroid plexus. In addition, barrier permeability can change during sleep, aging, systemic inflammation, and circadian cycles. The glymphatic system provides a partly separate route for fluid movement and waste clearance through perivascular spaces, rather than representing a simple opening in the endothelial barrier.⁴ These regional and temporal differences explain why a single permeability value cannot describe the whole brain.

Neurovascular unit

The interacting ensemble of endothelial cells, pericytes, astrocytes, neurons, microglia, and extracellular matrix that regulates cerebral vessels and barrier function.

Tight junction

A protein-based seal between adjacent endothelial cells that limits movement through the paracellular space.

Efflux transporter

A membrane protein that exports selected compounds from endothelial cells back into the bloodstream.

Circumventricular organ

A specialized central nervous system region with unusually permeable or fenestrated vessels that supports sensing or secretion.

Blood–cerebrospinal-fluid barrier

The selective interface at the choroid plexus and related sites that regulates exchange between blood and cerebrospinal fluid.